Evaluation and optimization of TCM comprehensive treatment plan in acute stage of cerebral hemorrhage

Phase 2

• Conditions: cerebral hemorrhage

• Registration Number: ITMCTR1900002629
• Lead Sponsor: Chengdu University of Traditional Chinese Medicine Clinical Medical College

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Aged 40 to 80 years;
2. Meet the diagnostic criteria for acute hemorrhagic stroke;
3. Acute cerebral hemorrhage onset time is less than 1 week;
4. NIHSS score >= 6 points;
5. Family or I sign a written informed consent form for participation in this trial.
Who meet the above 5 items at the same time can be included in the study.

Exclusion Criteria

1. It has been confirmed by examination that cerebral hemorrhage is caused by brain tumor, brain trauma, blood disease (secondary to anticoagulant and thrombolytic therapy), vascular malformation or cerebral aneurysm;
2. Surgical treatment of patients;
3. Pregnant, lactating women;
4. Onset is accompanied by severe heart disease, liver dysfunction, renal insufficiency, respiratory failure, malignant tumors, gastrointestinal bleeding, etc.;
5. Psychiatric patients;
6. Participating in other clinical trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality rate;Absorption rate of hematoma;

Secondary Outcome Measures

Name	Time	Method
Glasgow Score;NIHSS;BI;Quality of life;mRs;